FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

21995011000001100: Mirabegron 50mg modified-release tablets (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 15-Oct 2014. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    72995201000001117 Mirabegron 50mg modified-release tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    72995301000001114 Mirabegron 50mg modified-release tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Mirabegron 50mg modified-release tablets Is a Mirabegron false Inferred relationship Existential restriction modifier
    Mirabegron 50mg modified-release tablets Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Mirabegron 50mg modified-release tablets Has specific active ingredient Mirabegron false Inferred relationship Existential restriction modifier
    Mirabegron 50mg modified-release tablets VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Mirabegron 50mg modified-release tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Mirabegron 50mg modified-release tablets Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Mirabegron 50mg modified-release tablets Has specific active ingredient Mirabegron false Inferred relationship Existential restriction modifier
    Mirabegron 50mg modified-release tablets Is a Product containing mirabegron false Inferred relationship Existential restriction modifier
    Mirabegron 50mg modified-release tablets Has active ingredient Mirabegron false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) Is a False Mirabegron 50mg modified-release tablets Inferred relationship Existential restriction modifier
    Mirabegron 50mg modified-release tablets 30 tablet Has VMP False Mirabegron 50mg modified-release tablets Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start